[{"id":"b9206b8e-f067-4cfc-b28d-58df478d8a27","acronym":"","url":"https://clinicaltrials.gov/study/NCT04609826","created_at":"2021-09-24T16:53:15.037Z","updated_at":"2024-07-02T16:35:01.156Z","phase":"Phase 1","brief_title":"A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)","source_id_and_acronym":"NCT04609826","lead_sponsor":"Janssen Research \u0026 Development, LLC","biomarkers":" BCL2","pipe":"","alterations":" ","tags":["BCL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e JNJ-6665"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 153","initiation":"Initiation: 11/26/2020","start_date":" 11/26/2020","primary_txt":" Primary completion: 07/31/2024","primary_completion_date":" 07/31/2024","study_txt":" Completion: 07/31/2024","study_completion_date":" 07/31/2024","last_update_posted":"2024-05-24"}]